Circ_0003945: an emerging biomarker and therapeutic target for human diseases

被引:0
|
作者
Zhang, Xiaofei [1 ]
Ma, Li [1 ]
Wan, Li [2 ]
Wang, Haoran [3 ]
Wang, Zhaoxia [1 ]
机构
[1] Nanjing Med Univ, Dept Urol, Affiliated Hosp 2, Nanjing, Peoples R China
[2] Nanjing Med Univ, Dept Oncol, Affiliated Huaian 1 Peoples Hosp, Huaian, Peoples R China
[3] Tongji Univ, Tongji Hosp, Sch Med, Dept Orthoped,Div Spine Surg, Shanghai, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2024年 / 14卷
基金
中国国家自然科学基金;
关键词
cancer; circ_0003945; ceRNA; biomarker; therapeutic target; COLORECTAL-CANCER; BREAST-CANCER; RNA; PROGRESSION; CIRCRNA; CERNA; TUMORIGENESIS; OSTEOSARCOMA; STATISTICS; BIOGENESIS;
D O I
10.3389/fonc.2024.1275009
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Due to the rapid development of RNA sequencing techniques, a circular non-coding RNA (ncRNA) known as circular RNAs (circRNAs) has gradually come into focus. As a distinguished member of the circRNA family, circ_0003945 has garnered attention for its aberrant expression and biochemical functions in human diseases. Subsequent studies have revealed that circ_0003945 could regulate tumor cells proliferation, migration, invasion, apoptosis, autophagy, angiogenesis, drug resistance, and radio resistance through the molecular mechanism of competitive endogenous RNA (ceRNA) during tumorigenesis. The expression of circ_0003945 is frequently associated with some clinical parameters and implies a poorer prognosis in the majority of cancers. In non-malignant conditions, circ_0003945 also holds considerable importance in diseases pathogenesis. This review aims to recapitulate molecular mechanism of circ_0003945 and elucidates its potential as a diagnostic and therapeutic target in neoplasms and other diseases.
引用
收藏
页数:16
相关论文
共 50 条
  • [1] Peptidylglycine α-amidating monooxygenase as a therapeutic target or biomarker for human diseases
    Merkler, David J.
    Hawley, Aidan J.
    Eipper, Betty A.
    Mains, Richard E.
    BRITISH JOURNAL OF PHARMACOLOGY, 2022, 179 (13) : 3306 - 3324
  • [2] Podoplanin: An emerging cancer biomarker and therapeutic target
    Krishnan, Harini
    Rayes, Julie
    Miyashita, Tomoyuki
    Ishii, Genichiro
    Retzbach, Edward P.
    Sheehan, Stephanie A.
    Takemoto, Ai
    Chang, Yao-Wen
    Yoneda, Kazue
    Asai, Jun
    Jensen, Lasse
    Chalise, Lushun
    Natsume, Atsushi
    Goldberg, Gary S.
    CANCER SCIENCE, 2018, 109 (05) : 1292 - 1299
  • [3] circ_0067934: A Potential Biomarker and Therapeutic Target for Hepatocellular Carcinoma
    Zhou, Changdong
    Li, Rui
    Mi, Wei
    ANNALS OF CLINICAL AND LABORATORY SCIENCE, 2020, 50 (06): : 734 - 738
  • [4] BCL11A: a potential diagnostic biomarker and therapeutic target in human diseases
    Yin, Jiawei
    Xie, Xiaoli
    Ye, Yufu
    Wang, Lijuan
    Che, Fengyuan
    BIOSCIENCE REPORTS, 2019, 39
  • [5] Autophagy: an emerging therapeutic target in vascular diseases
    Vindis, Cecile
    BRITISH JOURNAL OF PHARMACOLOGY, 2015, 172 (09) : 2167 - 2178
  • [6] Pericytes in Cerebrovascular Diseases: An Emerging Therapeutic Target
    Su, Xiaojuan
    Huang, Lingyi
    Qu, Yi
    Xiao, Dongqiong
    Mu, Dezhi
    FRONTIERS IN CELLULAR NEUROSCIENCE, 2019, 13
  • [7] NETosis: an emerging therapeutic target in renal diseases
    Juha, Mark
    Molnar, Adel
    Jakus, Zoltan
    Ledo, Nora
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [8] MANF: an emerging therapeutic target for metabolic diseases
    Tang, Qin
    Li, Yanping
    He, Jinhan
    TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2022, 33 (04): : 236 - 246
  • [9] Ferroptosis as an emerging therapeutic target in liver diseases
    Lu, Yuzhen
    Hu, Junjie
    Chen, Liang
    Li, Shan
    Yuan, Ming
    Tian, Xianxiang
    Cao, Peng
    Qiu, Zhenpeng
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [10] Characterization of hsa_circ_0000594 as a new biomarker and therapeutic target for hepatoblastoma
    Song, H.
    Bian, Z-X
    Li, H-Y
    Zhang, Y.
    Ma, J.
    Chen, S-H
    Zhu, J-B
    Zhang, X.
    Wang, J.
    Gu, S.
    Xu, M.
    Pan, Q-H
    Yin, M-Z
    Zheng, L.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2019, 23 (19) : 8274 - 8286